Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Allows BioNTech to Import mRNA COVID Vaccine – for Expats Only

publication date: Nov 4, 2022

China has agreed to let Germany's BioNTech bring its COVID mRNA vaccine to China – but only for expatriate use. The agreement came during an official state meeting between German Chancellor Olaf Scholz and China’s premier, Li Keqiang. China does not have an approved mRNA vaccine for its citizens, even though it has nine less effective vaccines from its domestic vaccine makers, none of which address the omicron variant. In early 2020, Fosun Pharma acquired China rights to BioNTech’s mRNA COVID vaccine before Pfizer bought rights for the rest of the world. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here